pelargonium sidoides callus
callus of pelargonium sidoides grown in culture
Identification
| Name | pelargonium sidoides callus |
| CAS Number | 1175005-95-4 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | antioxidants |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | antioxidants, hair conditioning, humectants |
| Recommendation for pelargonium sidoides callus usage levels up to | not for fragrance use. |
| Recommendation for pelargonium sidoides callus flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
callus of pelargonium sidoides grown in culture
south african
geranium callus
umckaloabo callus
PubMed:
Herbal Medicine for Cough: a Systematic Review and Meta-Analysis.
PubMed:
Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells.
PubMed:
Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.
PubMed:
A review of commercially important African medicinal plants.
PubMed:
The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes.
PubMed:
Reproduction of the Medicinal Plant Pelargonium sidoides via Somatic Embryogenesis.
PubMed:
Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis.
PubMed:
[Herbal medicines against respiratory diseases--traditional empiricism or pharmacological evidence?].
PubMed:
The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor.
PubMed:
Medicinal properties and conservation of Pelargonium sidoides DC.
PubMed:
EPs7630(®) from Pelargonium sidoides increases stress resistance in Caenorhabditis elegans probably via the DAF-16/FOXO pathway.
PubMed:
Pelargonium sidoides extract for treating acute respiratory tract infections.
PubMed:
Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies.
PubMed:
Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts.
PubMed:
Conservation strategy for Pelargonium sidoides DC: phenolic profile and pharmacological activity of acclimatized plants derived from tissue culture.
PubMed:
Herbal hepatotoxicity: suspected cases assessed for alternative causes.
PubMed:
Herbal medicine, randomised controlled trials and global core competencies.
PubMed:
Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD.
PubMed:
Adverse effects of herbal medicines: an overview of systematic reviews.
PubMed:
Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children?
PubMed:
Treatment of the common cold in children and adults.
PubMed:
African Geranium (EPs 7630), part 2: the efficacy of Pelargonium sidoides (EPs 7630) in the treatment of acute bronchitis in adults and children.
PubMed:
Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
PubMed:
The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy.
PubMed:
Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained?
PubMed:
 Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement.
PubMed:
Synergistic Antimycobacterial Actions of Knowltonia vesicatoria (L.f) Sims.
PubMed:
EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
PubMed:
Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained?
PubMed:
Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents.
PubMed:
African geranium (EPs 7630), part I: a proprietary root extract of Pelargonium sidoides (EPs 7630) is found to be effective in resolving symptoms associated with the common cold in adults.
PubMed:
[Pelargonium sidoides - oral (Kaloban).].
PubMed:
[Pelargonium sidoides in acute bronchitis - Health-related quality of life and patient-reported outcome in adults receiving EPs 7630 treatment].
PubMed:
Anti-infective activities of Pelargonium sidoides (EPS® 7630): effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay.
PubMed:
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses.
PubMed:
Anti-adhesive activities of flavan-3-ols and proanthocyanidins in the interaction of group A-streptococci and human epithelial cells.
PubMed:
Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs® 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells.
PubMed:
Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15.
PubMed:
An evidence-based systematic review of umckaloabo (Pelargonium sidoides) by the Natural Standard Research Collaboration.
PubMed:
Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae).
PubMed:
Determination of umckalin in commercial tincture and phytopreparations containing Pelargonium sidoides by HPLC: comparison of sample preparation procedures.
PubMed:
Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
PubMed:
Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots.
PubMed:
Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis.
PubMed:
Benzopyranones and their sulfate esters from Pelargonium sidoides.
PubMed:
Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial.
PubMed:
Components derived from Pelargonium stimulate macrophage killing of Mycobacterium species.
PubMed:
A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae).
PubMed:
Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
PubMed:
Pelargonium sidoides extract for acute respiratory tract infections.
PubMed:
Anti-infective mode of action of EPs 7630 at the molecular level.
PubMed:
A broad review of commercially important southern African medicinal plants.
PubMed:
EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial.
PubMed:
A detailed view on the constituents of EPs 7630.
PubMed:
Extract of Pelargonium sidoides (EPs 7630) displays anti-infective properties by enhanced phagocytosis and differential modulation of host-bacteria interactions.
PubMed:
Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis.
PubMed:
Aqueous ethanolic extract of the roots of Pelargonium sidoides--new scientific evidence for an old anti-infective phytopharmaceutical.
PubMed:
Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
PubMed:
[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].
PubMed:
Allergic reactions to medicines derived from Pelargonium species.
PubMed:
Large molecules as anti-adhesive compounds against pathogens.
PubMed:
An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach.
PubMed:
Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.
PubMed:
Liquid herbal drug preparation from the root of Pelargonium sidoides is effective against acute bronchitis: results of a double-blind study with 124 patients.
PubMed:
Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models.
PubMed:
In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630.
PubMed:
Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.
PubMed:
EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells.
PubMed:
Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.
PubMed:
EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitis.
PubMed:
Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro.
PubMed:
Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children.
PubMed:
Inhibition of lipopolysaccharid-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs 7630) in mice.
PubMed:
Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro.
PubMed:
Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (Eps 7630).
PubMed:
Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial.
PubMed:
Tannins and related compounds induce nitric oxide synthase and cytokines gene expressions in Leishmania major-infected macrophage-like RAW 264.7 cells.
PubMed:
A new approach to pharmacological effects on ciliary beat frequency in cell cultures--exemplary measurements under Pelargonium sidoides extract (EPs 7630).
PubMed:
Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
PubMed:
Pharmacological profile of extracts of Pelargonium sidoides and their constituents.
PubMed:
Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
PubMed:
Immunomodulatory principles of Pelargonium sidoides.
PubMed:
Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme.